1Innis, SM, Pinsk, V & Jacobson, K (2006) Dietary lipids and intestinal inflammatory disease. J Pediatr 149, S89–S96.
2Lakatos, PL (2006) Recent trends in the epidemiology of inflammatory bowel diseases: up or down? World J Gastroenterol 12, 6102–6108.
3Monteleone, G, Peluso, I, Fina, D, Caruso, R, Andrei, F, Tosti, C & Pallone, F (2006) Bacteria and mucosal immunity. Dig Liver Dis 38, S256–S260.
4Caradonna, L, Amati, L, Magrone, T, Pellagrino, NM, Jirillo, E & Caccavo, D (2000) Enteric bacteria, lipopolysaccharides and related cytokines in inflammatory bowel disease: biological and clinical significance. J Endotoxin Res 6, 205–214.
5Bouma, G & Strober, W (2003) The immunological and genetic basis of inflammatory bowel disease. Nat Rev Immunol 3, 521–533.
6Marano, CW, Lewis, SA, Garulacan, AP, Soler, LA & Mullin, JM (1998) Tumor necrosis factor-α increases sodium and chloride conductance across the tight junction of CACO-2 BBE, a human intestinal epithelial cell line. J Membr Biol 161, 263–274.
7Mullin, JM & Snock, KV (1990) Effect of tumour necrosis factor on epithelial tight junctions and transepithelial permeability. Cancer Res 50, 2172–2176.
8Satsu, H, Ishimoto, Y, Nakano, T, Mochizuki, T, Iwanaga, T & Shimizu, M (2006) Induction by activated macrophage-like THP-1 cells of apoptotic and necrotic cell death in intestinal epithelial Caco-2 monolayers via tumor necrosis factor-α. Exp Cell Res 312, 3909–3919.
9Yu, Y, Correll, PH & Vanden Heuvel, JP (2002) Conjugated linoleic acid decreases production of pro-inflammatory products in macrophages: evidence for a PPARγ-dependent mechanism. Biochim Biophys Acta 1581, 89–99.
10Daynes, RA & Jones, DC (2002) Emerging roles of PPARs in inflammation and immunity. Nat Rev Immunol 2, 748–759.
11Kersten, S, Desvergne, B & Wahli, W (2000) Roles of PPAR in health and disease. Nature 405, 421–424.
12Loscher, CE, Draper, E, Leavy, O, Kelleher, D, Mills, KHG & Roche, HM (2005) Conjugated linoleic acid suppresses NF-κB activation and IL-12 production in dendritic cells through ERK-mediated IL-10 induction. J Immunol 175, 4990–4998.
13Bassaganya-Riera, J, Hontecillas, R & Beitz, DC (2002) Colonic anti- inflammatory mechanisms of conjugated linoleic acid. Clin Nutr 21, 451–459.
14Hontecillas, R, Wannemeulher, MJ, Zimmerman, DR, Hutto, DL, Wilson, JH, Ahn, DU & Bassaganya-Riera, J (2002) Nutritional regulation of porcine bacterial-induced colitis by conjugated linoleic acid. J Nutr 132, 2019–2027.
15Bassaganya-Riera, J & Hontecillas, R (2006) CLA and n-3 PUFA differentially modulate clinical activity and colonic PPAR-responsive gene expression in a pig model of experimental IBD. Clin Nutr 25, 454–465.
16Riserus, U, Vessby, B, Arnlov, J & Basu, S (2004) Effects of cis-9, trans-11 conjugated linoleic acid supplementation on insulin sensitivity, lipid peroxidation, and proinflammatory markers in obese men. Am J Clin Nutr 80, 279–283.
17Griinari, JM, Corl, BA, Lacy, SH, Chouinard, PY, Nurmela, KV & Bauman, DE (2000) Conjugated linoleic acid is synthesized endogenously in lactating diary cows by δ (9)-desaturase. J Nutr 130, 2285–2291.
18Ntambi, JM (1995) The regulation of stearoyl-CoA desaturase. Prog Lipid Res 34, 139–150.
19Mahfouz, MM, Valicenti, AJ & Holman, RT (1980) Desaturation of isomeric trans-octadecenoic acids by rat liver microsomes. Biochim Biophys Acta 18, 1–12.
20Renaville, B, Mullen, A, Moloney, F, Larondelle, Y, Schneider, YJ & Roche, HM (2006) Eicosapentaenoic acid and 3,10 dithia stearic acid inhibit the desaturation of trans-vaccenic acid into cis-9 trans-11-conjugated linoleic acid through different pathways in Caco-2 and T84 cells. Br J Nutr 95, 688–695.
21Bligh, EG & Dyer, WJ (1959) A rapid method for total lipid extraction and purification. Can J Biochem Physiol 37, 911–917.
22Park, T, Albright, KJ, Liu, W, Storkson, JM, Cook, ME & Pariza, MW (1997) Effect of conjugated linoleic acid on body composition in mice. Lipids 32, 853–858.
23Eulitz, K, Yurawecz, MP, Sehat, N, Fritsche, J, Roach, JA, Mossoba, MM, Kramer, JKG, Adlof, RO & Ku, Y (1999) Preparation, separation, and confirmation of the eight geometrical cis/trans conjugated linoleic acid isomers 8,10- through 11, 13–18:2. Lipids 34, 873–877.
24Ringseis, R, Gahler, S, Herter, C & Eder, K (2006) Conjugated linoleic acids exert similar actions on prostanoid release from aortic and coronary artery smooth muscle cells. Int J Vitam Nutr Res 76, 281–289.
25Toomey, S, McMonagle, J & Roche, HM (2006) Conjugated linoleic acid: a functional nutrient in the different pathophysiological components of the metabolic syndrome? Curr Opin Clin Nutr Metab Care 9, 740–747.
26Logan, RF (1998) Inflammatory bowel disease incidence: up, down or unchanged? Gut 42, 309–311.
27Bassaganya-Riera, J, Reynolds, K, Martino-Catt, S, Cui, Y, Hennighausen, L, Gonzalez, F, Rohrer, J, Benninghoff, AU & Hontecillas, R (2004) Activation of PPAR γ and δ by conjugated linoleic acid mediates protection from experimental inflammatory bowel disease. Gastroenterology 127, 777–791.
28Li, B, Birdwell, C & Whelan, J (1994) Antithetic relationship of dietary arachidonic acid and eicosapentaenoic acid on eicosanoid production in vivo. J Lipid Res 35, 1869–1877.
29Hwang, DM, Kundu, JK, Shin, JW, Lee, JC, Lee, HJ & Surh, YJ (2007) Cis-9 trans-11-conjugated linoleic acid down-regulates phorbol ester-induced NF-κB activation and subsequent COX-2 expression in hairless mouse skin by targeting IκB kinase and PI3K-Akt. Carcinogenesis 28, 363–371.